Dr. Alex Zheutlin was interviewed by Medscape Cardiology to discuss his publication in JAMA Network Open: "Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial". Dr. Zheutlin stated in the interview that, "overall, we found that therapeutic inertia was similar in different races in the SPRINT trial. We did not see disparities that have been reported in previous observational studies... These results show that a well-resourced approach in which a standardized approach to blood pressure measurement and treatment intensification is followed can overcome the racial disparity that is seen in therapeutic inertia and the treatment of blood pressure." Dr. Zheutlin’s research interests involve improving cardiovascular outcomes using prediction modeling incorporating environment, genomic, and clinical data. He has been an exemplary participant in the Utah StARR program, and the program directors have been thrilled with his drive and consistent work. Congratulations Dr. Zheutlin!